Chemotherapy Administration and Survival in Soft Tissue Sarcoma

August 7, 2014
Sujana Movva, MD

Sujana Movva, MD, medical oncologist, Fox Chase Cancer Center, discusses an analysis of chemotherapy administration and survival in soft tissue sarcoma.

Clinical Pearls

Sujana Movva, MD, medical oncologist, Fox Chase Cancer Center, discusses an analysis ofchemotherapy administration and survival in soft tissue sarcoma.

  • This was a National Cancer Database analysis looking at patterns of chemotherapy administration and survival in stage III soft tissue sarcoma (STS).
  • Chemotherapy administration in this population of patients may vary across the country.
  • This analysis showed an overall survival benefit for chemotherapy in stage III STS after adjusting for comorbidities.